Literature DB >> 9342452

Prevention of edema disease in pigs by vaccination with verotoxin 2e toxoid.

M Johansen1, L O Andresen, S E Jorsal, L K Thomsen, T E Waddell, C L Gyles.   

Abstract

Pigs in 2 herds with persistent problems with post weaning edema disease caused by infection with verotoxin-2e (VT2e)-producing Escherichia coli O139 were treated with a VT2e-toxoid vaccine. Treatment was performed as a randomized blind field trial with parallel treatment and non-vaccinated control groups. In 1 herd, a group of pigs was injected with adjuvant alone. Pigs were vaccinated at 1 and 3 wk of age and weaned at 4 wk of age. The effect of vaccination was measured by average daily weight gain (ADG), mortality due to edema disease within the 1st 4 wk after weaning, and weight at 3-6 mo of age. Pathological and microbiological examinations were performed on all pigs that died during the 1st 4 wk post weaning. Only pigs from which VT2e+, F18+ E. coli O139 was isolated were categorized as "death due to edema disease." The serological response to vaccination was evaluated by an indirect ELISA. Vaccination had a statistically significant effect on the level of antibodies specific for VT2e in both herds. Vaccination resulted in a statistically significant increase in ADG in the nursery period but not in the grower-finishing period. Vaccination had a statistically significant effect on mortality due to edema disease with an odds ratio of 0.039, indicating that there was almost total elimination of mortality due to the disease in the vaccine groups.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9342452      PMCID: PMC1189422     

Source DB:  PubMed          Journal:  Can J Vet Res        ISSN: 0830-9000            Impact factor:   1.310


  10 in total

1.  Immunization of pigs with a purified Shiga-like toxin II variant toxoid.

Authors:  D L MacLeod; C L Gyles
Journal:  Vet Microbiol       Date:  1991-11       Impact factor: 3.293

2.  An experimental model for subclinical edema disease (Escherichia coli enterotoxemia) manifest as vascular necrosis in pigs.

Authors:  F M Kausche; E A Dean; L H Arp; J E Samuel; H W Moon
Journal:  Am J Vet Res       Date:  1992-03       Impact factor: 1.156

3.  The production of oedema disease and diarrhoea in weaned pigs by the oral administration of Escherichia coli: factors that influence the course of the experimental disease.

Authors:  H W Smith; S Halls
Journal:  J Med Microbiol       Date:  1968-08       Impact factor: 2.472

4.  Prevalence of F107 fimbriae on Escherichia coli isolated from pigs with oedema disease or postweaning diarrhoea.

Authors:  H Imberechts; H U Bertschinger; M Stamm; T Sydler; P Pohl; H De Greve; J P Hernalsteens; M Van Montagu; P Lintermans
Journal:  Vet Microbiol       Date:  1994-06       Impact factor: 3.293

5.  Detection of fimbrial and toxin genes in Escherichia coli and their prevalence in piglets with diarrhoea. The application of colony hybridization assay, polymerase chain reaction and phenotypic assays.

Authors:  B Ojeniyi; P Ahrens; A Meyling
Journal:  Zentralbl Veterinarmed B       Date:  1994-03

6.  An enzymatic mutant of Shiga-like toxin II variant is a vaccine candidate for edema disease of swine.

Authors:  V M Gordon; S C Whipp; H W Moon; A D O'Brien; J E Samuel
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.441

7.  Vaccination with genetically modified Shiga-like toxin IIe prevents edema disease in swine.

Authors:  B T Bosworth; J E Samuel; H W Moon; A D O'Brien; V M Gordon; S C Whipp
Journal:  Infect Immun       Date:  1996-01       Impact factor: 3.441

8.  Reproduction of edema disease of swine with purified Shiga-like toxin-II variant.

Authors:  D L MacLeod; C L Gyles; B P Wilcock
Journal:  Vet Pathol       Date:  1991-01       Impact factor: 2.221

Review 9.  Infection by verocytotoxin-producing Escherichia coli.

Authors:  M A Karmali
Journal:  Clin Microbiol Rev       Date:  1989-01       Impact factor: 26.132

10.  Interaction of verotoxin 2e with pig intestine.

Authors:  T E Waddell; C A Lingwood; C L Gyles
Journal:  Infect Immun       Date:  1996-05       Impact factor: 3.441

  10 in total
  7 in total

1.  Prevention of edema disease in pigs by passive immunization.

Authors:  M Johansen; L O Andresen; L K Thomsen; M E Busch; H Wachmann; S E Jorsal; C L Gyles
Journal:  Can J Vet Res       Date:  2000-01       Impact factor: 1.310

2.  Protection of piglets against Edema disease by maternal immunization with Stx2e toxoid.

Authors:  Thi Kim Nguyen Oanh; Viet Khong Nguyen; Henri De Greve; Bruno Maria Goddeeris
Journal:  Infect Immun       Date:  2011-11-14       Impact factor: 3.441

3.  Mouse toxicity and cytokine release by verotoxin 1 B subunit mutants.

Authors:  V M Wolski; A M Soltyk; J L Brunton
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

4.  Effectiveness of F18+ Fimbrial Antigens Released by a Novel Autolyzed Salmonella Expression System as a Vaccine Candidate against Lethal F18+ STEC Infection.

Authors:  Gayeon Won; John H Lee
Journal:  Front Microbiol       Date:  2016-11-22       Impact factor: 5.640

5.  Implementation of a vaccine against Shigatoxin 2e in a piglet producing farm with problems of Oedema disease: case study.

Authors:  Regine Fricke; Olaf Bastert; Verena Gotter; Nico Brons; Johan Kamp; Hans-Joachim Selbitz
Journal:  Porcine Health Manag       Date:  2015-05-07

6.  Systematic review and network meta-analysis to compare vaccine effectiveness against porcine edema disease caused by Shiga toxin-producing Escherichia coli.

Authors:  Sim-In Lee; Eurade Ntakiyisumba; Gayeon Won
Journal:  Sci Rep       Date:  2022-04-19       Impact factor: 4.996

7.  Dietary supplementation with sodium gluconate improves the growth performance and intestinal function in weaned pigs challenged with a recombinant Escherichia coli strain.

Authors:  Yanyan Zhang; Dan Yi; Haiwang Xu; Zihan Tan; Yuxuan Meng; Tao Wu; Lei Wang; Di Zhao; Yongqing Hou
Journal:  BMC Vet Res       Date:  2022-08-06       Impact factor: 2.792

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.